Physician profile

Sanjay Bose

Interventional Cardiology · Paducah, KY

NPI 1225038698

$1,516.83

in general payments reported to CMS, 2019-2025

9 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$350.67

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Medtronic, INC. $777.87 2021-2022
Abbott Laboratories $332.92 2021-2024 Cardiomems, Dragonfly Opstar
Novartis Pharmaceuticals Corporation $255.96 2020-2023
Ethicon US, LLC $39.94 2021
Philips North America LLC $39.72 2023-2024 (6311) Epiq Cvx
Janssen Pharmaceuticals, INC $22.51 2019-2020
Cordis US Corp. $19.45 2024 Mynx Control
Alnylam Pharmaceuticals INC. $14.87 2024 Onpattro
Inspire Medical Systems, INC. $13.59 2024 Inspire

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Sanjay Bose

$1,516.83

in general payments reported 2019-2025

Years
2019-2024
Top company
Medtronic, INC.

https://glasscript.com/doctor/55576/sanjay-bose

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.